The Dialysafe trial aimed to reduce episodes of intradialytic hypotension during hemodialysis sessions at the clinic level.

Many prioritize comfort but also want intensive therapies ...

SAN DIEGO, CA / ACCESS Newswire / May 11, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company develop ...

The J&K Private Hospitals and Dialysis Centres Association today claimed that nearly 60 percent of payments under ...

Slowing progression remission quiet marks a shift in nephrology with Monogram Health’s holistic, algorithm-driven in-home ...

Added 7 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% ...

SeaStar Medical Holding Corporation (NASDAQ:ICU) is expanding its footprint in the pediatric acute kidney injury (AKI) market through continued Quellimmune adoption and education efforts. The company ...

The National Kidney Foundation (NKF) announced today that its Innovation Fund has invested in Biohope, a biotechnology company developing precision diagnostics designed to personalize ...

In a move to revitalize its transportation sector, the Special Development Zone of Mariel and the Ministry of Transport have ...

Leeds United fans have been urged to hold a 53rd minute applause during Sunday’s Brighton match at Elland Road for East Stand ...

Trump’s “tough Cuba policy” breaks with recent efforts toward rapprochement supported by the Catholic Church, with the aim of ...

Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc. (Nasdaq: APLS). Apellis, a leader in advancing treatments for serious, ...